Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Repligen Corp.

http://www.repligen.com

Latest From Repligen Corp.

Gilead Gets License To Compugen’s Potential First-In-Class IL-18 Target For Cancer

The company will pay $60m for rights to the preclinical asset COM503, which could be a new type of immuno-oncology drug.

Deals Cancer

Israeli Biopharma Leaders Focus On Near-Term Targets

Biopharma executives in Israel rely on their global footprint and a 'culture of resilience'.

Market Intelligence Innovation

Deal Watch: Merck KGAA Teams With AI Biotechs On Drug Discovery Efforts

Plus deals involving Debiopharm/SunRock, RefleXion/3B Pharmaceuticals, Pharmanovia/Sanofi and more.

Deal Watch Business Strategies

BioBytes: Four Big Pharma Companies Cultivating AI-Based Start-ups

Through an Israeli innovation lab, four big pharma companies are fostering AI-driven start-ups to help solve industry problems.

Innovation Artificial Intelligence
See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Synthesis Technologies, Production Processes
  • Other Names / Subsidiaries
    • Atoll GmBH
    • Avitide, Inc.
    • Bio-Flex Solutions LLC
    • C Technologies, Inc.
    • Newton T&M Corp.
    • Novozymes Biopharma Sweden AB
    • TangenX Technology Corporation
    • Polymem S.A.
UsernamePublicRestriction

Register